ATE188119T1 - Heilmittel für wunden und hämorrhoiden - Google Patents
Heilmittel für wunden und hämorrhoidenInfo
- Publication number
- ATE188119T1 ATE188119T1 AT93903319T AT93903319T ATE188119T1 AT E188119 T1 ATE188119 T1 AT E188119T1 AT 93903319 T AT93903319 T AT 93903319T AT 93903319 T AT93903319 T AT 93903319T AT E188119 T1 ATE188119 T1 AT E188119T1
- Authority
- AT
- Austria
- Prior art keywords
- wounds
- hemorrhoids
- remedies
- prostaglandin
- derivatives
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 title abstract 3
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 208000014617 hemorrhoid Diseases 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 abstract 1
- LMHIPJMTZHDKEW-XQYLJSSYSA-M Epoprostenol sodium Chemical compound [Na+].O1\C(=C/CCCC([O-])=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 LMHIPJMTZHDKEW-XQYLJSSYSA-M 0.000 abstract 1
- 229960000711 alprostadil Drugs 0.000 abstract 1
- 229960001123 epoprostenol Drugs 0.000 abstract 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
- 150000003174 prostaglandin I2 derivatives Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2280892 | 1992-02-07 | ||
JP18986792 | 1992-06-24 | ||
PCT/JP1993/000151 WO1993015739A1 (en) | 1992-02-07 | 1993-02-05 | Remedy for wound or hemorrhoid |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE188119T1 true ATE188119T1 (de) | 2000-01-15 |
Family
ID=26360087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93903319T ATE188119T1 (de) | 1992-02-07 | 1993-02-05 | Heilmittel für wunden und hämorrhoiden |
Country Status (8)
Country | Link |
---|---|
US (3) | US5403867A (OSRAM) |
EP (1) | EP0583482B1 (OSRAM) |
JP (1) | JP3209427B2 (OSRAM) |
AT (1) | ATE188119T1 (OSRAM) |
CA (1) | CA2107669C (OSRAM) |
DE (1) | DE69327432T2 (OSRAM) |
TW (1) | TW234691B (OSRAM) |
WO (1) | WO1993015739A1 (OSRAM) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
JP3209427B2 (ja) * | 1992-02-07 | 2001-09-17 | 科研製薬株式会社 | 創傷または痔疾治療剤 |
JP3971454B2 (ja) * | 1993-10-29 | 2007-09-05 | ザ トラスティーズ オブ ボストン ユニバーシティ | 抗新生物剤としての酪酸、酪酸塩、および誘導体の生理学的に安定な組成物 |
US5962477A (en) * | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
US6190691B1 (en) | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
IT1269634B (it) * | 1994-05-06 | 1997-04-08 | Indena Spa | Medicamento topico ad attivita' cicatrizzante |
WO1995033465A1 (fr) * | 1994-06-02 | 1995-12-14 | Teijin Limited | Composition pharmaceutique pour le traitement de troubles du systeme circulatoire peripherique |
CA2181364A1 (en) * | 1994-11-17 | 1996-05-30 | Kaneto Uekama | Preparation for percutaneous absorption |
AU4732096A (en) * | 1995-02-27 | 1996-09-18 | Toray Industries, Inc. | Remedy for pulmonary heart |
US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
US6573282B1 (en) | 1995-09-12 | 2003-06-03 | Adolor Corporation | Peripherally active anti-hyperalgesic opiates |
US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
US5869059A (en) * | 1996-01-16 | 1999-02-09 | Mon's Tea Partnership | Herbal composition for hemorrhoid treatment |
CA2324426A1 (en) * | 1998-02-11 | 1999-08-19 | Douglas V. Faller | Compositions and methods for the treatment of cystic fibrosis |
US6365198B1 (en) * | 2001-01-28 | 2002-04-02 | Gulf Pharmaceutical Industries | Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids |
US20040266880A1 (en) * | 2002-02-22 | 2004-12-30 | Fumie Sato | Antipruritics |
KR100904583B1 (ko) * | 2002-08-09 | 2009-06-25 | 다이쇼 세이야꾸 가부시끼가이샤 | 지양제 |
US7737182B2 (en) * | 2002-08-09 | 2010-06-15 | Taisho Pharmaceutical Co., Ltd. | Pharmaceuticals for xerosis |
JP2006522136A (ja) | 2003-04-02 | 2006-09-28 | ネックスメド ホールディングス インコーポレイテッド | プロスタグランジン組成物および血管痙攣の治療のためのその使用 |
WO2005000316A1 (ja) * | 2003-06-25 | 2005-01-06 | Cardiovascular Institute, Ltd. | 性交機能改善用外用製剤 |
GB0524103D0 (en) * | 2005-11-26 | 2006-01-04 | Medical Res Council | Healing |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
MA33899B1 (fr) | 2009-12-08 | 2013-01-02 | Hemaquest Pharmaceuticals Inc | Procedes et regimes a faible dose pour des troubles des globules rouges |
WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
CA2838109C (en) | 2011-04-07 | 2020-06-09 | Nexmed Holdings, Inc. | Topical semisolid prostaglandin e1 composition for treating raynaud's disease |
US9345678B2 (en) | 2013-03-13 | 2016-05-24 | Allergan, Inc. | Prostanoid receptor agonist compounds and methods of use for same |
AU2020283590A1 (en) | 2019-05-31 | 2022-01-20 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK142235B (da) * | 1974-12-20 | 1980-09-29 | Yamanouchi Pharma Co Ltd | Analogifremgangsmåde til fremstilling af 20-alkoxy-16-methyl-prostadiensyre-derivater. |
US4025645A (en) * | 1976-01-27 | 1977-05-24 | Jelenko Iii Carl | Non-steroid topical agent for alleviating inflammation in mammals |
GB1595056A (en) * | 1976-10-12 | 1981-08-05 | Wellcome Found | Pharmaceutical combination |
JPS5391110A (en) * | 1977-01-20 | 1978-08-10 | Yamanouchi Pharmaceut Co Ltd | Novel drug composition for rectal infusion |
US4260603A (en) * | 1979-01-02 | 1981-04-07 | Pegel Karl H | Sterol glycoside with activity as prostaglandin synthetase inhibitor |
DE3162659D1 (en) * | 1980-07-22 | 1984-04-19 | Ono Pharmaceutical Co | 9,11-methano-13-aza-11a-carbathrombanoic acid analogues and pharmaceutical use thereof |
DE3631169A1 (de) * | 1986-09-11 | 1988-03-24 | Schering Ag | Prostacyclinderivate enthaltende mittel fuer die topische anwendung |
DE3886936T2 (de) * | 1987-10-16 | 1994-04-28 | Toray Industries | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG. |
JPH0311017A (ja) * | 1989-06-06 | 1991-01-18 | Green Cross Corp:The | プロスタグランジンe↓1含有薬剤組成物 |
ES2093774T3 (es) * | 1991-03-14 | 1997-01-01 | R Tech Ueno Ltd | Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. |
JP3209427B2 (ja) * | 1992-02-07 | 2001-09-17 | 科研製薬株式会社 | 創傷または痔疾治療剤 |
SG66248A1 (en) * | 1993-02-03 | 1999-07-20 | Teijin Ltd | External skin treatment agent composition containing prostacyclins as active ingredient |
-
1993
- 1993-02-05 JP JP51394793A patent/JP3209427B2/ja not_active Expired - Fee Related
- 1993-02-05 DE DE69327432T patent/DE69327432T2/de not_active Expired - Fee Related
- 1993-02-05 AT AT93903319T patent/ATE188119T1/de not_active IP Right Cessation
- 1993-02-05 CA CA002107669A patent/CA2107669C/en not_active Expired - Fee Related
- 1993-02-05 WO PCT/JP1993/000151 patent/WO1993015739A1/ja active IP Right Grant
- 1993-02-05 US US08/129,157 patent/US5403867A/en not_active Expired - Lifetime
- 1993-02-05 EP EP93903319A patent/EP0583482B1/en not_active Expired - Lifetime
- 1993-03-09 TW TW082101725A patent/TW234691B/zh active
-
1994
- 1994-12-27 US US08/365,516 patent/US5679707A/en not_active Expired - Lifetime
-
1997
- 1997-07-09 US US08/890,443 patent/US5852050A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0583482A1 (en) | 1994-02-23 |
EP0583482A4 (en) | 1995-05-03 |
US5852050A (en) | 1998-12-22 |
DE69327432T2 (de) | 2000-05-18 |
DE69327432D1 (de) | 2000-02-03 |
US5679707A (en) | 1997-10-21 |
WO1993015739A1 (en) | 1993-08-19 |
CA2107669C (en) | 2004-06-01 |
US5403867A (en) | 1995-04-04 |
TW234691B (OSRAM) | 1994-11-21 |
JP3209427B2 (ja) | 2001-09-17 |
CA2107669A1 (en) | 1993-08-08 |
EP0583482B1 (en) | 1999-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE188119T1 (de) | Heilmittel für wunden und hämorrhoiden | |
AU549481B2 (en) | Hair growing agent | |
EP0427247A3 (en) | Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
ES2159591T3 (es) | Composicion de liberacion controlada. | |
EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
ES2055860T3 (es) | Derivados 2-aminopirimidinona. | |
ES2058892T3 (es) | Uso de omeprazol como agente antimicrobiano. | |
NO171365C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
FI870457A0 (fi) | Farmaceutiska preparatformer foer stabilisering av interferon- . | |
ATE173627T1 (de) | Medizinische zusammensetzung | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
ATE80616T1 (de) | Prostaglandin e1-derivate und ihre therapeutische anwendung. | |
ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
DE69024060D1 (de) | Osteogenesis-stimulierende mittel. | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
ATE73784T1 (de) | Fungizide 2-anilinthiazoline. | |
PT862433E (pt) | Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval | |
HK8994A (en) | Medicament for treatment of pregnancy-induced hypertension | |
ES2124926T3 (es) | Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas. | |
UA12937A (uk) | Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом | |
TH20329A (th) | สิ่งป้องกันโรคและสิ่งหรือยาใช้รักษาโรคสำหรับบาดแผล และ/หรือการอักเสบซึ่งเกี่ยวกับตา | |
UA23369A (uk) | Антисептичний перев`язний матеріал |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |